|
Avanir Pharmaceuticals,Incorporation - Company Profile Snapshot
| Company Profile: |
Avanir Pharmaceuticals,Incorporation |
| Ticker: |
AVNR |
| Exchanges: |
NAS |
| 2008 Sales: |
3,342,500 |
| Major Industry: |
Miscellaneous |
| Sub Industry: |
Medical Services |
| Country: |
UNITED STATES |
| Employees: |
20 |
Business Description
Avanir Pharmaceuticals,Incorporation Formerly known as AVANIR Pharmaceuticals. The Group's principal activity is to develop, acquire and commercialize novel therapeutic products for the treatment of chronic diseases. The product candidate address therapeutic markets that include the central nervous system and inflammatory diseases. The product candidate Zenvia is in the phase III clinical development for the treatment of pseudobulbar affect and diabetic peripheral neuropathic pain. The Group also has an ongoing development program with Novartis for the treatment of inflammatory disease.
|
Not the Report you are looking for?
Click here for more browsing options.
|
The following information is available to subscribers or can be accessed by purchasing the Company Profile Report:
|
- Address (mailing), Phone Number, Web Address
- Earnings/Dividends
- Employees
- Exchanges Listed
- Financial Ratio Analysis |
- Recent Stock Performance
- Sales (recent year)
- Senior Officers
- Shareholder Information
- Stock Analysis Summary |
Layout and Content of a Typical Report
|
|
|
|
|
